| Original Research Online Published: 01 Feb 2019 | ||||||||||||||||||||||||||||||
Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung .
| ||||||||||||||||||||||||||||||
| How to Cite this Article |
| Pubmed Style . Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. Int J Med Sci Public Health. 2019; 8(3): 243-247. doi:10.5455/ijmsph.2019.0102028012019 Web Style . Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. https://www.ijmsph.org/?mno=27801 [Access: October 10, 2025]. doi:10.5455/ijmsph.2019.0102028012019 AMA (American Medical Association) Style . Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. Int J Med Sci Public Health. 2019; 8(3): 243-247. doi:10.5455/ijmsph.2019.0102028012019 Vancouver/ICMJE Style . Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. Int J Med Sci Public Health. (2019), [cited October 10, 2025]; 8(3): 243-247. doi:10.5455/ijmsph.2019.0102028012019 Harvard Style (2019) Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. Int J Med Sci Public Health, 8 (3), 243-247. doi:10.5455/ijmsph.2019.0102028012019 Turabian Style . 2019. Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. International Journal of Medical Science and Public Health, 8 (3), 243-247. doi:10.5455/ijmsph.2019.0102028012019 Chicago Style . "Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung." International Journal of Medical Science and Public Health 8 (2019), 243-247. doi:10.5455/ijmsph.2019.0102028012019 MLA (The Modern Language Association) Style . "Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung." International Journal of Medical Science and Public Health 8.3 (2019), 243-247. Print. doi:10.5455/ijmsph.2019.0102028012019 APA (American Psychological Association) Style (2019) Prospective comparative study of pemetrexed and carboplatin versus paclitaxel and carboplatin as first-line chemotherapy in adenocarcinoma lung. International Journal of Medical Science and Public Health, 8 (3), 243-247. doi:10.5455/ijmsph.2019.0102028012019 |
